Clinical trial
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
NCT00471120 · Dick Domanik, Industry · Terminated
Key facts
| NCT number | NCT00471120 |
|---|---|
| Title | Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer |
| Official title | Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women |
| Lead sponsor | Dick Domanik, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Uterine Cancer, Endometrial Cancer |
| Intervention type | Other |
| Interventions | P2x7 assay |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | May 9, 2007 |
| Last update posted | Aug 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: